PIZENSY
Peaklactitol
NDAORALSOLUTION
Approved
Feb 2020
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
2/8 — Basic
Drug data last refreshed 4h ago · AI intelligence enriched 4h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PIZENSY is an oral solution formulation of lactitol, a disaccharide osmotic laxative used to treat constipation. Lactitol works by drawing water into the intestinal lumen and promoting bowel motility through osmotic action. It is indicated for patients requiring gentle, osmotic-based bowel regulation.
Peak10.6 years to LOE
Product is in peak commercial phase with established market presence; core team likely stable but not expanding rapidly given lack of competitive pressure.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
PIZENSY offers limited current job market visibility (0 linked roles), reflecting either niche product status or saturated staffing in stable peak phase. Career opportunity lies in lifecycle management and market optimization within a predictable, low-growth commercial environment with strong patent protection through 2037.
Brand ManagerField Sales Representative
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.